The biological characteristics of a 17-kDa protein synthesized in bacterial cells, a TNF-binding domain (VARV-TNF-BP) of a 47-kDa variola virus CrmB protein (VARV-CrmB) consisting of TNF-binding and chemokine-binding domains, were studied. Removal of the C-terminal chemokine-binding domain from VARV-CrmB protein was inessential for the effi ciency of its inhibition of TNF cytotoxicity towards L929 mouse fi broblast culture and for TNF-induced oxidative metabolic activity of mouse blood leukocytes. The results of this study could form the basis for further studies of VARV-TNF-BP mechanisms of activity for prospective use in practical medicine.
Similar content being viewed by others
References
I. P. Gileva, E. M. Malkova, E. S. Nepomnyashchikh, et al., Tsitokin. Vospal., 5, No. 1, 44-49 (2006).
I. P. Gileva, T. S. Nepomnyashchikh, I. A. Ryazankin, and S. N. Shchelkunov, Biokhimiya, 74, No. 12, 1664-1671 (2009).
I.P. Gileva, I. A. Ryazankin, T. S. Nepomnyashchikh, et al., Mol. Biol., 39, No. 2, 245-254 (2005).
L. R. Lebedev, I. A. Ryazankin, A. A. Sizov, et al., Biotekhnol., No. 6, 14-18 (2001).
T. S. Nepomnyashchikh, D. V. Antonets, I. P. Gileva, and S. N. Shchelkunov, Uspekhi Sovrem. Biol., 127, No. 6, 558-569 (2007).
T. V. Tregubchak, T. S. Nepomnyashchikh, D. V. Antonets, and S. N. Shchelkunov, Patent RF No. 2471869. Recombinant DNA Plasmids pQE-60-TNFR-CrmB-Ind-67 and pFastBac1- G2R-dSECRET, containing Variola Virus Genome Fragment Coding for Tumor Necrosis Factor, Binding CrmB Protein Domain and Bv/G2R-dSECRET Baculovirus Strain, Producing Secretory TNF-Binding Protein of Variola Virus CrmB with Deleted Secret Domain, Bull. No. 1 (January 10, 2013).
D. D. Tsyrendorzhiev, S. V. Sennikov, E. A. Vyazovaya, et al., Byull. Sib. Otdel. Ross. Akad. Med. Nauk, 31, No. 3, 73-79 (2011).
D. D. Tsyrendorzhiev, S. V. Sennikov, I. A. Orlovskaya, et al., Immunol., 32, No. 4, 209-213 (2011).
A. Alejo, M. B. Ruiz-Arguello, Y. Ho, et al., Proc. Natl. Acad. Sci. USA, 103, No. 15, 5995-6000 (2006).
J. M. Bathon, R. W. Martin, R. M. Fleischmann, et al., N. Engl. J. Med., 343, No. 22, 1586-1593 (2000).
M. M. Bradford, Anal. Biochem., 72, 248-254 (1976).
I. P. Gileva, T. S. Nepomnyashchikh, D. V. Antonets, et al., Biochim. Biophys. Acta, 1764, No. 11, 1710-1718 (2006).
S. A. Siegel, D. J. Shealy, M. T. Nakada, et al., Cytokine, 7, No. 1, 15-25 (1995).
T. Tono-oka, N. Ueno, T. Matsumoto, et al., Clin. Immunol. Immunopathol., 26, No. 1, 66-75 (1983).
M. E. Weinblatt, E. C. Keystone, D. E. Furst, et al., Arthritis Rheum., 48, No. 1, 35-45 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsyrendorzhiev, D.D., Orlovskaya, I.A., Sennikov, S.V. et al. Biological Effects of Individually Synthesized TNF-Binding Domain of Variola Virus CrmB Protein. Bull Exp Biol Med 157, 249–252 (2014). https://doi.org/10.1007/s10517-014-2537-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-014-2537-6